Drugs / Colchicine
Colchicine
also known as
Colcrys · LODOCO · (S)-N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9 oxobenzol\[a\]heptalen-7-yl) acetamide · COLC · Colchcine · COLCHICINA LIRCA · Colchicine component of col-probenecid · Colchicine component of colbenemid · +15 more
Small molecule targets CYP1A2, NLRP3, TNF via inhibition
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | GLOPERBA | — | 2024-08-28 | fda.gov ↗ |
| Approved | US (FDA) | COLBENEMID | — | 1961-07-27 | fda.gov ↗ |
Trials 176 · started per year
today
US approved 1961
1
1
1
1
3
6
9
4
5
2
1
7
9
3
2
4
4
5
20
18
15
8
17
14
15
1
19601961196219631964196519661967196819691970197119721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT06212271 | Sep 2024 → Mar 2026 | peripheral arterial disease | University of Pennsylvania | Completed | No outcome recorded |
| Phase 0 | NCT02083510 | Feb → May 2014 | gout, hypertriglyceridemia, pericarditis | Scripps Translational Science Institute | Completed | No outcome recorded |
| Phase 129 trials | ||||||
| Phase 1 | NCT06874192 | Mar 2025 → May 2026 | statin toxicity | Virginia Commonwealth University | Completed | No outcome recorded |
| Phase 1 | NCT06567678 | Aug → Oct 2024 | coronary artery disorder | The University of The West Indies | Completed | No outcome recorded |
| Phase 1 | NCT05335148 | May 2022 → Jun 2026 overdue | — | Rutgers, The State University of New Jersey | Active not recruiting | No outcome recorded |
| Phase 1 | NCT05347316 | Mar 2022 → Mar 2023 | atherosclerosis, coronary artery disorder, inflammatory disease | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
| Phase 1 | NCT05279690 | Feb 2022 → Dec 2024 | metastatic neoplasm, urothelial carcinoma | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
| Phase 1 | NCT05324423 | Oct 2021 → Aug 2022 | gout | The Affiliated Hospital of Qingdao University | Unknown | No outcome recorded |
| Phase 1 | NCT05151614 | Apr → Oct 2021 | COVID-19 | University of Baghdad | Completed | No outcome recorded |
| Phase 1 | NCT04355585 | May 2020 → Apr 2023 | — | Brigham and Women's Hospital | Unknown | No outcome recorded |
| Phase 1 | NCT03131583 | Feb 2017 → Jan 2018 | gout | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT01075906 | Aug 2010 → Dec 2011 | familial Mediterranean fever | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01123395 | May → Jun 2010 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01130051 | May → Jun 2010 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01001052 | Oct 2009 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00960193 | Feb → Apr 2009 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00960323 | Feb → Mar 2009 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00983242 | Sep → Oct 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00984009 | Sep → Oct 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00983905 | Aug → Sep 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00983931 | Aug → Sep 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00983372 | Aug 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00983294 | Jul → Aug 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00983216 | Jul → Aug 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00983515 | Jul → Aug 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01018420 | Nov → Dec 2007 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00984061 | Nov → Dec 2007 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01017042 | Sep 2007 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01017003 | Sep → Oct 2007 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01040845 | Aug 2007 → Jan 2008 | — | Mutual Pharmaceutical Company, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00004368 | May 1990 → ? | cirrhosis of liver | National Center for Research Resources (NCRR) | Unknown | No outcome recorded |
| Phase 1/23 trials · 1 missed | ||||||
| Phase 1/2 | NCT04392141 | Apr → Nov 2020 | COVID-19 | Kermanshah University of Medical Sciences | Completed | No outcome recorded |
| Phase 1/2 | NCT02442921 | Feb 2016 → Apr 2019 | diabetic kidney disease | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 1/2 | NCT02153983 | May 2014 → Aug 2018 | metabolic disease, obesity disorder | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | Missed primary |
| Phase 235 trials · 1 met primary · 4 missed | ||||||
| Phase 2 | NCT07856719 | Mar 2027 → Jul 2032 expected | head and neck cancer | M.D. Anderson Cancer Center | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06855433 | Aug 2026 → Apr 2030 expected | crystal arthropathy | Brigham and Women's Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT07704164 | Jun 2026 → Dec 2028 expected | HIV infectious disease, cardiovascular disorder | Instituto de Investigación Hospital Universitario La Paz | Recruiting | No outcome recorded |
| Phase 2 | NCT07837934 | Jul 2025 → Jul 2027 expected | atherosclerosis, type 2 diabetes mellitus | Tan Tock Seng Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT07026994 | Jun 2025 → Dec 2027 expected | cerebral amyloid angiopathy, intracerebral hemorrhage | Huashan Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT06813079 | Apr 2025 → Feb 2028 expected | pancreatic ductal adenocarcinoma | University Health Network, Toronto | Recruiting | No outcome recorded |
| Phase 2 | NCT06130059 | Apr 2024 → Jul 2026 overdue | heart failure | University of Texas Southwestern Medical Center | Recruiting | No outcome recorded |
| Phase 2 | NCT06081049 | Jan 2024 → Jun 2026 | diastolic heart failure | Tor Biering-Sørensen | Unknown | No outcome recorded |
| Phase 2 | NCT06062277 | Oct 2023 → Oct 2024 | atherosclerosis, ischemic stroke | University College Dublin | Unknown | No outcome recorded |
| Phase 2 | NCT05677555 | Nov 2022 → Feb 2023 | end stage renal failure | Assaf-Harofeh Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT05159219 | Aug 2022 → Dec 2024 | intracerebral hemorrhage | Population Health Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT05472337 | Aug 2022 → Mar 2026 overdue | acute coronary syndrome | Pontificia Universidad Catolica de Chile | Recruiting | No outcome recorded |
| Phase 2 | NCT05250596 | Feb 2022 → Feb 2024 | acute coronary syndrome | Azienda USL Toscana Centro | Completed | No outcome recorded |
| Phase 2 | NCT05017571 | Nov 2021 → Sep 2025 | obesity disorder | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
| Phase 2 | NCT04500665 | Nov 2021 → Jul 2026 overdue | chronic kidney disease | Brigham and Women's Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT04916522 | Aug 2021 → Jan 2026 overdue | hypertensive disorder | Herlev and Gentofte Hospital | Active not recruiting | No outcome recorded |
| Phase 2 | NCT06731595 | May 2021 → Jan 2022 | atrial fibrillation, pericarditis | St. Vincent Cardiovascular Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT04906720 | May 2021 → Jan 2022 | atrial fibrillation, pericarditis | St. Vincent Cardiovascular Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT04756128 | Jan → Nov 2021 | COVID-19 | HealthPartners Institute | Completed | No outcome recorded |
| Phase 2 | NCT04403243 | May → Jul 2020 | COVID-19 | Lomonosov Moscow State University Medical Research and Educational Center | Completed | No outcome recorded |
| Phase 2 | NCT04355143 | May 2020 → Jul 2021 | COVID-19 | University of California, Los Angeles | Completed | Missed primary |
| Phase 2 | NCT04322565 | Apr 2020 → Sep 2021 | COVID-19, viral pneumonia | Azienda Ospedaliero-Universitaria di Parma | Completed | No outcome recorded |
| Phase 2 | NCT04375202 | Apr 2020 → Oct 2021 | COVID-19 | University Of Perugia | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT04326790 | Apr 2020 | COVID-19 | National and Kapodistrian University of Athens | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT04264260 | Dec 2019 → May 2025 | combined hepatocellular carcinoma and cholangiocarcinoma, hepatocellular carcinoma, intrahepatic cholangiocarcinoma | Kaohsiung Medical University Chung-Ho Memorial Hospital | Completed | Met primary |
| Phase 2 | NCT03704181 | Oct 2018 → Dec 2020 | Chagas disease | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT03156816 | Jul 2018 → Nov 2020 | myocardial infarction | Hospices Civils de Lyon | Completed | Missed primary |
| Phase 2 | NCT02939573 | Jan 2017 → Dec 2028 expected | cutaneous polyarteritis nodosa, cutaneous vasculitis, immunoglobulin A vasculitis | University of Pennsylvania | Recruiting | No outcome recorded |
| Phase 2 | NCT02624180 | Nov 2015 → Aug 2020 | HIV infectious disease, coronary atherosclerosis | Johns Hopkins University | Completed | Missed primary |
| Phase 2 | NCT02366091 | Jan 2015 → Aug 2020 | coronary artery disorder | Johns Hopkins University | Completed | Missed primary |
| Phase 2 | NCT02162303 | May 2014 → Jul 2015 | atherosclerotic cardiovascular disease | Montreal Heart Institute | Completed | No outcome recorded |
| Phase 2 | NCT01935700 | Jun 2013 → May 2019 | hepatocellular carcinoma, metastatic carcinoma | Kaohsiung Medical University Chung-Ho Memorial Hospital | Completed | No outcome recorded |
| Phase 2 | NCT01481233 | May → Aug 2013 | prostate cancer | Milton S. Hershey Medical Center | Withdrawn | No outcome recorded Stop: Business |
| Phase 2 | NCT01005121 | Dec 2009 → Dec 2014 | diabetic kidney disease | Prof.Avi Livneh | Unknown | No outcome recorded |
| Phase 2 | NCT00819585 | Dec 2008 → Aug 2010 | gout | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 2/37 trials · 2 missed | ||||||
| Phase 2/3 | NCT07611019 | Jul 2026 → Jul 2028 expected | — | National Taiwan University Hospital | Enrolling by invitation | No outcome recorded |
| Phase 2/3 | NCT07571681 | Jul 2026 → Jul 2027 expected | Hashimoto thyroiditis, subacute thyroiditis | Mansoura University | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT05253794 | Jul 2022 → Jul 2024 | aortic valve stenosis | Ottawa Heart Institute Research Corporation | Completed | No outcome recorded |
| Phase 2/3 | NCT04420624 | Dec 2020 → May 2022 | acute myocardial infarction | University Hospital, Montpellier | Terminated | No outcome recorded |
| Phase 2/3 | NCT04492358 | Oct 2020 → May 2021 | COVID-19 | Maria Joyera Rodríguez | Terminated | Missed primary Stop: Enrollment |
| Phase 2/3 | NCT03575572 | Aug 2018 → Jan 2021 | heart disorder, univentricular heart | University of Michigan | Terminated | No outcome recorded |
| Phase 2/3 | NCT02176460 | Oct 2013 → Sep 2015 | osteoarthritis, knee | Singapore General Hospital | Completed | Missed primary |
| Phase 348 trials · 3 met primary · 4 missed | ||||||
| Phase 3 | NCT06587737 | Sep 2026 → Jul 2028 expected | intracerebral hemorrhage, substance dependence | Population Health Research Institute | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07232069 | Jul 2026 → Jul 2031 expected | atherosclerosis, coronary artery disorder | Duke University | Recruiting | No outcome recorded |
| Phase 3 | NCT07536373 | Jun 2026 → Apr 2029 expected | limb ischemia | Shin Kong Wu Ho-Su Memorial Hospital | Recruiting | No outcome recorded |
| Phase 3 | NCT07432529 | Jun 2026 → Jun 2027 expected | post-thrombotic syndrome, venous thromboembolism | Azienda Sanitaria Locale ASL 6, Livorno | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06440694 | Jul 2025 → Dec 2027 expected | venous thromboembolism | Ottawa Hospital Research Institute | Recruiting | No outcome recorded |
| Phase 3 | NCT07035405 | Jul 2025 → Dec 2028 expected | stroke disorder | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06930885 | Jun 2025 → May 2031 expected | atherosclerotic cardiovascular disease | Hospital do Coracao | Recruiting | No outcome recorded |
| Phase 3 | NCT06279000 | Apr 2025 → Mar 2028 expected | cardiovascular disorder | Cantonal Hospital of St. Gallen | Recruiting | No outcome recorded |
| Phase 3 | NCT07280572 | Feb 2025 → Dec 2027 expected | post-COVID-19 disorder | Janneke van de Wijgert | Enrolling by invitation | No outcome recorded |
| Phase 3 | NCT06578182 | Jan 2025 → Mar 2029 expected | osteoarthritis, hip, osteoarthritis, knee | Sint Maartenskliniek | Recruiting | No outcome recorded |
| Phase 3 | NCT06352632 | Sep 2024 → Sep 2034 expected | stroke disorder | The George Institute | Recruiting | No outcome recorded |
| Phase 3 | NCT05855746 | Jul 2024 → Jan 2028 expected | acute myocarditis | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
| Phase 3 | NCT06472908 | Jul 2024 → Jun 2027 expected | coronary artery disorder | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06837623 | Jul 2024 → Feb 2025 overdue | heart failure | Cairo University | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06469528 | Jun 2024 → Oct 2025 overdue | coronary artery disorder | King's College Hospital NHS Trust | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05890664 | Apr 2024 → Mar 2027 expected | atrial fibrillation | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
| Phase 3 | NCT06095765 | Jan 2024 → Nov 2027 expected | coronary artery disorder | AZ Sint-Jan AV | Recruiting | No outcome recorded |
| Phase 3 | NCT06118034 | Jan 2024 → Aug 2026 overdue | heart disorder, inflammatory disease | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Recruiting | No outcome recorded |
| Phase 3 | NCT06158698 | Nov 2023 → May 2026 overdue | cardiac rhythm disease, heart failure, myocarditis | Niguarda Hospital | Recruiting | No outcome recorded |
| Phase 3 | NCT05928728 | Jul 2023 → Jun 2026 overdue | atrial fibrillation | Herlev and Gentofte Hospital | Recruiting | No outcome recorded |
| Phase 3 | NCT05476991 | May 2023 → Sep 2027 expected | atherosclerosis, cerebral infarction, coronary artery disorder, myocardial infarction +1 | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
| Phase 3 | NCT05175274 | Dec 2022 → Mar 2027 expected | coronary artery disorder | Qingdao Central Hospital | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05734612 | Dec 2022 → Mar 2023 | myocardial stunning | Indonesia University | Unknown | No outcome recorded |
| Phase 3 | NCT05439356 | Aug 2022 → Jul 2023 | transient ischemic attack | Beijing Tiantan Hospital | Completed | No outcome recorded |
| Phase 3 | NCT05802992 | Mar 2022 → Dec 2024 | plasma cell myeloma | Affiliated Hospital of Nantong University | Unknown | No outcome recorded |
| Phase 3 | NCT04870424 | Sep 2021 → May 2024 | atrial fibrillation | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
| Phase 3 | NCT04705987 | Feb 2021 → May 2024 | heart failure | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Completed | No outcome recorded |
| Phase 3 | NCT04724629 | Jan → Mar 2021 | COVID-19 | University of Sao Paulo | Completed | No outcome recorded |
| Phase 3 | NCT04667780 | Dec 2020 → Jul 2021 | COVID-19 | Ayub Teaching Hospital | Completed | No outcome recorded |
| Phase 3 | NCT04472611 | Oct 2020 → Mar 2022 | COVID-19 | Yale University | Completed | Missed primary |
| Phase 3 | NCT04416334 | Aug 2020 → Jun 2022 | COVID-19 | Marqués de Valdecilla Research Institute (IDIVAL) | Completed | No outcome recorded |
| Phase 3 | NCT04181996 | Aug 2020 → Dec 2025 | atherosclerosis, diabetes mellitus | Ottawa Heart Institute Research Corporation | Completed | No outcome recorded |
| Phase 3 | NCT04350320 | Apr → Oct 2020 | COVID-19 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Completed | No outcome recorded |
| Phase 3 | NCT04324463 | Apr 2020 → Dec 2022 | severe acute respiratory syndrome | Population Health Research Institute | Completed | Missed primary |
| Phase 3 | NCT06054100 | Feb 2020 → Feb 2022 | ST-elevation myocardial infarction, acute coronary syndrome | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT04160117 | Jan 2020 → May 2022 | atrial fibrillation | Population Health Research Institute | Completed | Missed primary |
| Phase 3 | NCT04008316 | Nov 2019 → Nov 2022 | immunoglobulin A vasculitis | Assistance Publique - Hôpitaux de Paris | Unknown | No outcome recorded |
| Phase 3 | NCT03310125 | Feb 2018 → Jul 2023 | atrial fibrillation, atrial flutter, myocardial disorder | Population Health Research Institute | Completed | Missed primary |
| Phase 3 | NCT02582190 | Dec 2017 → Sep 2018 | atrial fibrillation | Elpen Pharmaceutical Co. Inc. | Withdrawn | No outcome recorded |
| Phase 3 | NCT02177266 | May 2015 → Nov 2016 | atrial fibrillation | Mayo Clinic | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT02282098 | Nov 2014 → Nov 2020 | atrial fibrillation, stroke disorder | Population Health Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT01985425 | Apr 2014 → Apr 2015 | atrial fibrillation | Population Health Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT00506883 | Apr → Oct 2007 | gout | Takeda | Completed | Met primary |
| Phase 3 | NCT00128414 | Aug 2005 → Apr 2009 | pericarditis | Azienda Sanitaria Locale 3, Torino | Completed | Met primary |
| Phase 3 | NCT00128427 | Jun 2005 → Jun 2010 | — | Azienda Sanitaria Locale 3, Torino | Completed | Met primary |
| Phase 3 | NCT00370201 | Mar 2004 → Aug 2006 | rhegmatogenous retinal detachment | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 3 | NCT00000577 | Sep 1993 → Jul 2008 | asthma, lung disorder | Milton S. Hershey Medical Center | Withdrawn | No outcome recorded |
| Phase 3 | NCT00004748 | Nov 1989 → ? | cirrhosis of liver | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
| Phase 441 trials · 4 met primary · 3 missed | ||||||
| Phase 4 | NCT06936709 | Dec 2026 → Jan 2027 expected | osteoarthritis, knee | Geisinger Clinic | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07362966 | Jun 2026 → Dec 2027 expected | clonal hematopoiesis of indeterminate potential, coronary atherosclerosis | Shenyang Northern Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT07462325 | Mar 2026 → Mar 2027 expected | coronary artery disorder | Chinese Academy of Medical Sciences, Fuwai Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07287345 | Jan → Dec 2026 expected | atrial fibrillation, colchicine poisoning | Ayesha Ather | Recruiting | No outcome recorded |
| Phase 4 | NCT07349875 | Jan 2026 → Dec 2029 expected | coronary artery disorder | Nanjing First Hospital, Nanjing Medical University | Recruiting | No outcome recorded |
| Phase 4 | NCT06802926 | Dec 2025 → Dec 2027 expected | — | Ruijin Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT06765356 | Apr 2025 → Mar 2027 expected | paroxysmal atrial fibrillation, persistent atrial fibrillation | Vivek Reddy | Active not recruiting | No outcome recorded |
| Phase 4 | NCT06798714 | Jan → Jul 2025 | atrial fibrillation, coronary artery disorder | Tomsk Cardiology Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT06604611 | Oct 2024 → Dec 2025 overdue | heart failure | Dongying Zhang | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06543082 | Aug 2024 → Dec 2028 expected | acute coronary syndrome | CHA University | Recruiting | No outcome recorded |
| Phase 4 | NCT06286423 | Jun 2024 → Jun 2026 overdue | symptomatic heart failure | University of Virginia | Recruiting | No outcome recorded |
| Phase 4 | NCT06280976 | Mar 2024 → Jan 2025 | atherosclerosis, coronary artery disorder, myocardial infarction | University of Louisville | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT06090890 | Oct 2023 → Oct 2026 expected | coronary restenosis | Fu Wai Hospital, Beijing, China | Recruiting | No outcome recorded |
| Phase 4 | NCT06025071 | Sep 2023 → Sep 2025 | coronary artery disorder | Chinese Academy of Medical Sciences, Fuwai Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT06020300 | Jul → Dec 2023 | ST-elevation myocardial infarction | National University of Malaysia | Unknown | No outcome recorded |
| Phase 4 | NCT06102720 | Jan 2023 → Jan 2025 | ischemic stroke | Mikhail Zykov | Unknown | No outcome recorded |
| Phase 4 | NCT05709509 | Jun 2022 → May 2023 | ST-elevation myocardial infarction | RSD dr. Soebandi | Unknown | No outcome recorded |
| Phase 4 | NCT05130892 | Nov 2021 → Feb 2023 | — | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Completed | No outcome recorded |
| Phase 4 | NCT04949516 | Jun 2021 → Dec 2022 | acute coronary syndrome | Wonkwang University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04848857 | May 2021 → Aug 2023 | acute coronary syndrome | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Completed | Met primary |
| Phase 4 | NCT04818489 | Mar → Aug 2021 | COVID-19, pulmonary fibrosis | ClinAmygate | Unknown | No outcome recorded |
| Phase 4 | NCT04601883 | Jan 2021 → Aug 2022 | osteoarthritis, hand | Henning Bliddal | Completed | Missed primary |
| Phase 4 | NCT04382443 | Mar 2020 → Apr 2022 | acute coronary syndrome, atherosclerosis, coronary restenosis | Centro de estudios en Cardiologia Intervencionista | Completed | No outcome recorded |
| Phase 4 | NCT04224545 | Dec 2019 → Aug 2022 | atrial fibrillation, colchicine poisoning | Bakulev Scientific Center of Cardiovascular Surgery | Completed | No outcome recorded |
| Phase 4 | NCT03933007 | Sep → Oct 2019 | gout | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 4 | NCT03913442 | May 2019 → Jan 2024 | osteoarthritis, knee | NYU Langone Health | Completed | No outcome recorded |
| Phase 4 | NCT02995512 | May 2017 → Sep 2018 | myocardial infarction | NYU Langone Health | Withdrawn | No outcome recorded |
| Phase 4 | NCT02926248 | May 2016 → Mar 2020 | — | Hospital for Special Surgery, New York | Suspended | No outcome recorded |
| Phase 4 | NCT02281305 | Oct 2014 → Apr 2015 | acute myocardial infarction | G.Gennimatas General Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02260206 | Jul 2014 → Sep 2019 | pericardial effusion | Yong Seog Oh | Completed | No outcome recorded |
| Phase 4 | NCT02140372 | May 2014 → Jan 2015 | — | NYU Langone Health | Completed | No outcome recorded |
| Phase 4 | NCT02122484 | Nov 2013 → Jun 2014 | — | G.Gennimatas General Hospital | Completed | Met primary |
| Phase 4 | NCT01936285 | Jul 2013 → Apr 2015 | acute myocardial infarction | G.Gennimatas General Hospital | Unknown | Met primary |
| Phase 4 | NCT01709981 | May 2013 → Aug 2019 | coronary artery disorder | NYU Langone Health | Completed | No outcome recorded |
| Phase 4 | NCT02060552 | Jan 2013 → Mar 2014 | gout | Tongji Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01601132 | May → Jul 2012 | — | Takeda | Completed | Missed primary |
| Phase 4 | NCT02602028 | Apr 2011 → Apr 2013 | familial Mediterranean fever | University of Health Sciences Gulhane Faculty of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT01266694 | Apr 2011 → Mar 2013 | pericardial effusion | French Cardiology Society | Completed | Missed primary |
| Phase 4 | NCT01173107 | Dec 2010 | chronic kidney disease | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01084278 | May 2010 → Feb 2011 | — | Takeda | Completed | No outcome recorded |
| Phase 4 | NCT00235079 | Nov 2005 → Dec 2011 | pericarditis | Azienda Sanitaria Locale 3, Torino | Completed | Met primary |
| Phase not applicable11 trials | ||||||
| — | NCT07569328 | Sep 2026 → Sep 2028 expected | coronary artery disorder | Beijing Anzhen Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07411768 | Mar 2026 → Jun 2028 expected | thrombotic disease | China National Center for Cardiovascular Diseases | Not yet recruiting | No outcome recorded |
| — | NCT07064109 | Jul 2025 → Jul 2027 expected | acute coronary syndrome | Shanghai Tongji Hospital, Tongji University School of Medicine | Recruiting | No outcome recorded |
| — | NCT06215989 | Sep 2024 → Feb 2027 expected | ST-elevation myocardial infarction, acute coronary syndrome, intermediate coronary syndrome | Beijing Anzhen Hospital | Recruiting | No outcome recorded |
| — | NCT05785429 | Aug 2022 → Jan 2025 | — | Donders Centre for Cognitive Neuroimaging | Completed | No outcome recorded |
| — | NCT05361772 | Jun 2022 → Jun 2024 | abdominal aortic aneurysm | Guangdong Provincial People's Hospital | Unknown | No outcome recorded |
| — | NCT05038449 | Sep 2021 → Jun 2023 | COVID-19 | Shanghai Public Health Clinical Center | Unknown | No outcome recorded |
| — | NCT05956145 | Jun 2021 → Apr 2024 | coronary artery disorder, platelet aggregation, spontaneous | University of Sao Paulo | Completed | No outcome recorded |
| — | NCT04139655 | Sep 2020 → Sep 2021 | infectious disease, myocardial infarction | University of British Columbia | Withdrawn | No outcome recorded |
| — | NCT04303689 | Aug 2020 → Dec 2022 | essential hypertension | University of Copenhagen | Completed | No outcome recorded |
| — | NCT02095522 | Mar 2014 → Jan 2016 | myocardial infarction | Tel-Aviv Sourasky Medical Center | Withdrawn | No outcome recorded |
| Comparator or background therapy105 trials | ||||||
| Phase 0 | NCT07143136 Comparator | Aug 2025 → Mar 2026 overdue | myocardial infarction | Assiut University | Recruiting | No outcome recorded |
| Phase 0 | NCT06426537 Comparator | Oct 2022 → Mar 2023 | ST-elevation myocardial infarction | University of Brawijaya | Completed | No outcome recorded |
| Phase 0 | NCT05118737 Comparator | Oct 2021 → Apr 2022 | pneumonia | Hamad Medical Corporation | Unknown | No outcome recorded |
| Phase 1 | NCT06203977 Comparator | Nov 2024 → May 2026 overdue | chronic kidney disease, kidney failure | Hamilton Health Sciences Corporation | Recruiting | No outcome recorded |
| Phase 1 | NCT06304896 Comparator | May 2024 → May 2025 | chemotherapy-induced toxicity | Arab Contractors Medical Centre | Unknown | No outcome recorded |
| Phase 1 | NCT01160276 Comparator | May 2010 → Jan 2012 | — | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 1/2 | NCT06847204 Comparator | Feb → May 2025 | COVID-19 | Zaeema Kanwal | Completed | No outcome recorded |
| Phase 1/2 | NCT04790240 Comparator | Jan 2025 → Dec 2026 expected | COVID-19 | All Natural Medicine Clinic, LLC | Recruiting | No outcome recorded |
| Phase 1/2 | NCT05637398 Comparator | Dec 2022 → Sep 2025 | heart failure | I.M. Sechenov First Moscow State Medical University | Completed | No outcome recorded |
| Phase 1/2 | NCT04762771 Comparator | Dec 2020 → May 2021 | COVID-19 | Baptist Health South Florida | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT07813858 Comparator | Oct 2026 → May 2028 expected | amyotrophic lateral sclerosis | University Hospital of Modena | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07708181 Comparator | Aug 2026 → Aug 2027 expected | gout | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07654231 Comparator | Jul 2026 → Dec 2027 expected | atherosclerotic cardiovascular disease, chronic kidney disease, diabetes mellitus, hyperlipidemia +2 | University of Texas Southwestern Medical Center | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07247734 Comparator | Dec 2025 → Dec 2026 expected | type 1 diabetes mellitus | Asger Lund, MD | Recruiting | No outcome recorded |
| Phase 2 | NCT04218786 Comparator | Dec 2025 → Mar 2026 | myocardial infarction, myocardial ischemia | Shifa Tameer-e-Millat University | Withdrawn | No outcome recorded |
| Phase 2 | NCT07145229 Comparator | Aug 2025 → May 2026 overdue | gout | Atom Therapeutics Co., Ltd | Recruiting | No outcome recorded |
| Phase 2 | NCT06768294 Comparator | Jan 2025 → Jun 2026 overdue | chondrocalcinosis | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06270225 Comparator | Mar → Oct 2024 | gout | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05949281 Comparator | Aug 2023 → Jan 2031 expected | cardiovascular disorder, type 1 diabetes mellitus | Asger Lund, MD | Active not recruiting | No outcome recorded |
| Phase 2 | NCT05936268 Comparator | Jul 2023 → Feb 2024 | gout | Changchun GeneScience Pharmaceutical Co., Ltd. | Completed | Met primary |
| Phase 2 | NCT05936281 Comparator | Jul 2023 → Jan 2024 | gout | Changchun GeneScience Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT05503225 Comparator | Nov 2022 → Sep 2025 overdue | intracranial arteriosclerosis | Chinese University of Hong Kong | Recruiting | No outcome recorded |
| Phase 2 | NCT04857931 Comparator | Jun 2022 → Mar 2023 | heart failure | Montreal Heart Institute | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT05726019 Comparator | Feb 2022 → Dec 2025 | Dressler syndrome, acute coronary syndrome, atrial fibrillation, coronary artery disorder +1 | University of Sao Paulo General Hospital | Completed | No outcome recorded |
| Phase 2 | NCT04867226 Comparator | May → Jun 2021 | COVID-19 | Hawler Medical University | Completed | No outcome recorded |
| Phase 2 | NCT04367168 Comparator | May 2020 → Apr 2021 | COVID-19 | National Institute of Medical Sciences and Nutrition Salvador Zubiran | Terminated | No outcome recorded |
| Phase 2 | NCT04363437 Comparator | Apr → Jul 2020 | COVID-19 | Maimonides Medical Center | Terminated | No outcome recorded |
| Phase 2 | NCT04360980 Comparator | Mar 2020 → Jan 2021 | COVID-19 | Shahid Beheshti University of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT04130204 Background | Feb 2020 → May 2021 | gout | Dyve Biosciences, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT03693781 Comparator | Apr 2019 → Apr 2022 | amyotrophic lateral sclerosis | University Hospital of Modena | Completed | No outcome recorded |
| Phase 2 | NCT03888846 Background | Mar → Aug 2019 | Behcet disease | Ipekyolu Ilac Ltd. Sti | Completed | No outcome recorded |
| Phase 2 | NCT04056039 Comparator | Aug 2018 → Jun 2019 | cardiovascular disorder, rheumatoid arthritis | Hospital Central "Dr. Ignacio Morones Prieto" | Completed | No outcome recorded |
| Phase 2 | NCT03376698 Comparator | Jun 2017 → Mar 2022 | coronary artery disorder, diarrheal disease, type 2 diabetes mellitus | University of the Ryukyus | Completed | No outcome recorded |
| Phase 2 | NCT02330796 Comparator | Apr → Nov 2015 | gout | Revive Therapeutics, Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT02252835 Background | Aug → Dec 2014 | gout | Gilead Sciences | Completed | No outcome recorded |
| Phase 2 | NCT02128490 Background | May 2014 → Sep 2015 | gout | Takeda | Completed | Met primary |
| Phase 2 | NCT02063997 Comparator | Mar 2014 → Jan 2015 | gout | Gilead Sciences | Completed | Met primary |
| Phase 2 | NCT01755949 Comparator | Mar 2013 → Dec 2016 | atrial fibrillation | Mayo Clinic | Completed | No outcome recorded |
| Phase 2 | NCT01416402 Background | Aug → Oct 2011 | gout | Gilead Sciences | Completed | No outcome recorded |
| Phase 2 | NCT01399008 Background | Jun 2011 → Feb 2012 | gout | Gilead Sciences | Completed | No outcome recorded |
| Phase 2 | NCT01336686 Background | May → Nov 2011 | gout | Gilead Sciences | Completed | No outcome recorded |
| Phase 2 | NCT00840489 Comparator | Jan 2009 → Dec 2012 | chronic hepatitis C virus infection | Hospital Universitario Ramon y Cajal | Terminated | No outcome recorded |
| Phase 2 | NCT00723268 Comparator | May 2007 → Aug 2008 | mouth disorder | Mashhad University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2 | NCT00700297 Comparator | Aug 2002 → Oct 2005 | Behcet disease | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/3 | NCT06217120 Comparator | Mar 2024 → Oct 2025 | coronary microvascular disorder, diastolic heart failure | Montreal Heart Institute | Unknown | No outcome recorded |
| Phase 2/3 | NCT04359095 Comparator | Aug 2020 → Mar 2021 | COVID-19 | National University of Colombia | Completed | No outcome recorded |
| Phase 2/3 | NCT03905759 Comparator | Apr 2019 → Apr 2020 | atrial fibrillation | doaa rashwan | Unknown | No outcome recorded |
| Phase 2/3 | NCT00754819 Comparator | Apr 2008 → Sep 2009 | acute coronary syndrome | Hamilton Health Sciences Corporation | Completed | No outcome recorded |
| Phase 3 | NCT06763055 Comparator | Feb 2025 → Jan 2028 expected | intracerebral hemorrhage | The George Institute | Recruiting | No outcome recorded |
| Phase 3 | NCT06998862 Comparator | Feb 2025 → Dec 2028 expected | chronic kidney disease | Hospital General Universitario Gregorio Marañon | Recruiting | No outcome recorded |
| Phase 3 | NCT05873881 Comparator | Jan 2024 → Jun 2027 expected | heart failure | Hamilton Health Sciences Corporation | Recruiting | No outcome recorded |
| Phase 3 | NCT05739929 Comparator | Mar 2023 → Aug 2024 | coronary artery disorder | Helwan University | Unknown | No outcome recorded |
| Phase 3 | NCT05737680 Comparator | Feb 2023 → Dec 2024 | idiopathic recurrent pericarditis | Hippocration General Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT05162742 Comparator | Dec 2022 → Dec 2025 overdue | aortic valve calcification, aortic valve stenosis, calcinosis | Radboud University Medical Center | Active not recruiting | No outcome recorded |
| Phase 3 | NCT05633810 Comparator | Dec 2022 → Dec 2027 expected | cardiovascular disorder, type 2 diabetes mellitus | Montreal Heart Institute | Recruiting | No outcome recorded |
| Phase 3 | NCT05459974 Comparator | Jun 2022 → Nov 2023 | atrial fibrillation | Stony Brook University | Unknown | No outcome recorded |
| Phase 3 | NCT04774159 Comparator | May 2021 → Dec 2029 expected | atherosclerosis, peripheral arterial disease | Population Health Research Institute | Recruiting | No outcome recorded |
| Phase 3 | NCT04539873 Comparator | Apr → Oct 2021 | COVID-19 | Fundación Universitaria de Ciencias de la Salud | Terminated | No outcome recorded |
| Phase 3 | NCT04516941 Comparator | Jan 2021 → Aug 2022 | COVID-19 | Insel Gruppe AG, University Hospital Bern | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT04997551 Comparator | Sep 2020 → Sep 2021 | COVID-19 | Biogipuzkoa Health Research Institute | Unknown | No outcome recorded |
| Phase 3 | NCT04328480 Comparator | Apr 2020 → Apr 2021 | COVID-19 | Estudios Clínicos Latino América | Completed | No outcome recorded |
| Phase 3 | NCT04322682 Comparator | Mar 2020 → Jan 2021 | COVID-19 | Montreal Heart Institute | Terminated | No outcome recorded |
| Phase 3 | NCT04381936 Comparator | Mar 2020 → Sep 2028 expected | pneumonia | University of Oxford | Recruiting | No outcome recorded |
| Phase 3 | NCT03128905 Comparator | Feb 2018 → May 2022 | chondrocalcinosis | Lille Catholic University | Completed | Met primary |
| Phase 3 | NCT03048825 Comparator | Feb 2018 → Aug 2024 | ST-elevation myocardial infarction | Population Health Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT03015831 Comparator | Oct 2017 → Apr 2019 | atrial fibrillation, colchicine poisoning | Jordan Collaborating Cardiology Group | Terminated | No outcome recorded |
| Phase 3 | NCT02898610 Comparator | Dec 2016 → Jan 2024 | transient ischemic attack | University College Dublin | Completed | No outcome recorded |
| Phase 3 | NCT02551094 Comparator | Dec 2015 → Jul 2019 | coronary artery disorder, myocardial infarction | Montreal Heart Institute | Completed | No outcome recorded |
| Phase 3 | NCT02139046 Background | Apr 2014 → Nov 2015 | gout | Takeda | Completed | Met primary |
| Phase 3 | NCT03021343 Comparator | Oct 2012 → Jan 2015 | cardiac rhythm disease | Jordan Collaborating Cardiology Group | Completed | No outcome recorded |
| Phase 3 | NCT01552187 Comparator | Mar 2012 → Jun 2014 | atrial fibrillation, pericardial effusion | Maria Vittoria Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT00370760 Comparator | Sep 2006 → ? | proliferative vitreoretinopathy | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 3 | NCT00128453 Comparator | Aug 2005 → Jun 2012 | pericarditis | Azienda Sanitaria Locale 3, Torino | Completed | No outcome recorded |
| Phase 4 | NCT07661030 Background | Jul 2026 → Jul 2027 expected | gout | First Affiliated Hospital of Wenzhou Medical University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06396858 Comparator | Jul 2026 → Aug 2027 expected | ischemic stroke | Brazilian Clinical Research Institute | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT04875702 Comparator | Feb 2024 → Sep 2028 expected | gout | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT05850091 Comparator | Dec 2023 → Jun 2027 expected | coronary artery disorder | Massachusetts General Hospital | Active not recruiting | No outcome recorded |
| Phase 4 | NCT06078904 Comparator | Oct → Dec 2023 | coronary artery disorder | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Completed | No outcome recorded |
| Phase 4 | NCT05618353 Comparator | Aug 2023 → Jul 2028 expected | coronary artery disorder | VA Office of Research and Development | Recruiting | No outcome recorded |
| Phase 4 | NCT06342609 Comparator | Mar 2023 → Sep 2024 | coronary atherosclerosis | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT05698680 Comparator | Jan 2023 → Feb 2026 | gout | University Medicine Greifswald | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT05200052 Comparator | Feb → Aug 2022 | myocardial infarction | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT05246072 Comparator | Nov 2021 → Feb 2022 | COVID-19 | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT04323280 Comparator | Feb 2020 → Jul 2023 | pericarditis | Rabin Medical Center | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT05168137 Comparator | Feb 2020 → Jun 2022 | HIV infectious disease, colchicine poisoning | Mahidol University | Unknown | No outcome recorded |
| Phase 4 | NCT03226899 Comparator | Jul 2017 → Feb 2019 | chronic kidney disease, gout | Ironwood Pharmaceuticals, Inc. | Terminated | No outcome recorded Stop: Business |
| Phase 4 | NCT02500641 Background | Aug 2015 → May 2017 | gout | Menarini International Operations Luxembourg SA | Completed | Missed primary |
| Phase 4 | NCT01994226 Comparator | Jan 2014 → Mar 2016 | gout | Keele University | Completed | No outcome recorded |
| Phase 4 | NCT01906749 Comparator | Jun 2013 → Jun 2016 | acute coronary syndrome | Maria Vittoria Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02594111 Comparator | May 2013 → Aug 2019 | acute coronary syndrome, coronary artery disorder | VA Office of Research and Development | Completed | No outcome recorded |
| Phase 4 | NCT01451645 Comparator | Oct 2011 → Aug 2012 | gout | Regeneron Pharmaceuticals | Completed | No outcome recorded |
| Phase 4 | NCT01112982 Background | May 2010 → Dec 2014 | gout | University of South Florida | Completed | No outcome recorded |
| Phase 4 | NCT00179413 Comparator | Jan 2000 → Dec 2009 | cirrhosis of liver, fibrotic liver disease, hepatitis C virus infection | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| — | NCT07476625 Comparator | Apr 2026 → Mar 2027 expected | PFAPA syndrome | Wenjie Zheng | Not yet recruiting | No outcome recorded |
| — | NCT07074990 Comparator | Nov 2023 → Aug 2024 | infectious disease with sepsis | Tanta University | Completed | No outcome recorded |
| — | NCT04073797 Comparator | Mar 2023 → Oct 2025 overdue | atherosclerosis, familial hypercholesterolemia | University of Cambridge | Recruiting | No outcome recorded |
| — | NCT05930002 Comparator | Jul 2021 → Sep 2022 | COVID-19 | Ain Shams University | Completed | No outcome recorded |
| — | NCT05911022 Comparator | Jul 2021 → Aug 2022 | COVID-19 | Ain Shams University | Completed | No outcome recorded |
| — | NCT04697602 Comparator | Jan 2021 → Aug 2023 | gout | National Taiwan University Hospital | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT04527562 Comparator | Jul → Nov 2020 | COVID-19 | Dhaka Medical College | Completed | No outcome recorded |
| — | NCT04155879 Comparator | Nov 2019 → Nov 2022 | atrial fibrillation | Hillel Yaffe Medical Center | Unknown | No outcome recorded |
| — | NCT03735134 Comparator | Nov 2018 → Jul 2020 | myocardial infarction | Hillel Yaffe Medical Center | Unknown | No outcome recorded |
| — | NCT03659058 Comparator | Mar 2016 → Aug 2018 | fibrotic liver disease | Zagazig University | Completed | No outcome recorded |
| — | NCT02035891 Comparator | Dec 2013 → Sep 2019 | diabetic kidney disease | Chongqing Medical University | Unknown | No outcome recorded |
| — | NCT00983177 Comparator | Mar 2010 → Oct 2011 | calcific tendinitis | Bnai Zion Medical Center | Unknown | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2019-02-21 | Zydus Lifesciences Limited | Regulatory Zydus receives final approvals from the USFDA for Phytonadione Tablets and Colchicine Tablets zyduslife.com ↗
The group also received the final approval for Colchicine Tablets USP (US RLD – Colcrys), 0.6 mg. |
All press releases naming this drug 20 releases
Evidence & citations 28 cited values
Every value below carries the sentence it was read from. 283 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colchicine | “colchicine 0.6mg by mouth twice daily on Days 5-19, co-administered with theophylline 300mg (80mg/15ml) on the morning of Day 19” NCT01601132 ↗280“Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19” NCT04997551 ↗ “remdesivir (Veklury), Colchicine, anti-SARS-CoV-2 monoclonal antibodies, bamlanivimab, Casirivimab \& Imdevimab.” NCT04790240 ↗ “Dexamethasone 20MG once daily for 4 days with additional colchicine therapy for 3 months” NCT04323280 ↗ “Colchicine tablet 0.5 mg once-daily for two weeks, then twice daily for two weeks” NCT07247734 ↗ “Colchicine0.5 mg Oral Tablet” NCT05324423 ↗ “Drug: Colchicine” NCT04056039 ↗ |
| Known as | (S)-N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9 oxobenzol\[a\]heptalen-7-yl) acetamide | “The chemical name for colchicine is (S)-N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9 oxobenzol\[a\]heptalen-7-yl) acetamide.” NCT05890664 ↗ |
| Known as | COLC | “This prospective, single-arm pharmacodynamic study assessed the effect of colchicine (COLC) [Strides Pharma UK Ltd, Watford, Hertfordshire, England] 0.5 mg administered orally...” PMID 39826082 ↗ Jan 2025 |
| Known as | Colchcine | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | COLCHICINA LIRCA | “Colchicine 1 mg day (COLCHICINA LIRCA ® ACARPIA Farmaceutici S.r.l.)” NCT04224545 ↗ |
| Known as | Colchicine component of col-probenecid | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | Colchicine component of colbenemid | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | Colchicine component of mitigare | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | Colchicine component of proben-c | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | Colchicine Pill | “Drug: Colchicine Pill” NCT06855433 ↗ |
| Known as | Colchicine Tablets | “Colchicine Tablets (Each tablet contains colchicine 0.5mg)” NCT05038449 ↗ |
| Known as | Colchicine Tablets 0.5mg | “Colchicine 0.5 mg oral tablet (Colchicine Tablets 0.5mg, Synmosa)” NCT07536373 ↗ |
| Known as | Colchicinum | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | Colchineos | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | Colchisol | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | Colcrys | “Colchicine (Colcrys®)” NCT07287345 ↗ |
| Known as | Colcrys TM, Colchicine 0.6 mg | “Colcrys TM, Colchicine 0.6 mg” NCT00506883 ↗ |
| Known as | generic colchicine tablets (SIN 12490P) | “generic colchicine tablets (SIN 12490P)” NCT02176460 ↗ |
| Known as | Gloperba | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | LODOCO | “LODOCO is low-dose colchicine at 0.5mg daily, ii is an FDA approved anti-inflammatory drug, to prevent cardiovascular events in patients with coronary artery disease.” NCT06874192 ↗1“Intervention group will receive LoDoCo (Colchicine 0.5mg), oral, once daily.” NCT07654231 ↗ |
| Known as | Mitigare | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | NSC-757 | ChEMBL registry synonym — accepted as the source's own label CHEMBL107 ↗ |
| Known as | opocalcium | “Patients assigned to this group will receive the Colchicine opocalcium 1mg treatment.” NCT03128905 ↗ |
| Known as | Tiofarma | “The intervention tablets are commercially available Colchicine "Tiofarma"” NCT04601883 ↗ |
| Action | Inhibit | “Colchicine is a supressor of hepatic CYP1A2” NCT00983905 ↗ |
| Modality | Small molecule | “Colchicine is an alkaloid compound” NCT03933007 ↗ |
| Route | Oral | “Patients receive colchicine orally twice daily for 24 months.” NCT00004368 ↗ |
| Target | CYP1A2 | “Colchicine is a supressor of hepatic CYP1A2” NCT00983905 ↗ |